Source: Annual Congress 2009 - Inflammation and airways
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Guiot, J. Sele, M. Henket, R. Louis (Liège, Belgium). Eosinophilic inflammation and asthma control. Eur Respir J 2009; 34: Suppl. 53, 2128

Member's Comments

No comment yet.

Related content which might interest you: Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Eosinophilic asthma Source: Eur Respir Monogr 2022; 95: 73-99 Year: 2022 Eosinophilic refractory inflammation in OCS-dependent severe asthma Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments Year: 2021 Modulation of Eosinophilic airway inflammation in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 441s Year: 2005 Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017 Eosinophilic COPD Source: Eur Respir Monogr 2022; 95: 100-118 Year: 2022 Eosinophilic otitis media and eosinophilic asthma; shared pathophysiology and response to anti-IL5 Source: International Congress 2018 – CC7 Severe asthma Year: 2018 Eosinophilic inflammation in sputum of poorly controlled asthmatics Source: Eur Respir J 2002; 20: 1370-1377 Year: 2002 The importance of eosinophilic inflammation in COPD exacerbations Source: International Congress 2017 – COPD management Year: 2017 Asthma exacerbations and eosinophilic inflammation 6 months after treatment with mepolizumab in refractory eosinophilic asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009 Eosinophilic inflammation in COPD: prevalence and clinical characteristics Source: Eur Respir J 2014; 44: 1697-1700 Year: 2014 Effects of omalizumab on markers of eosinophilic inflammation in patients with severe allergic asthma Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 The pathological feature of airway inflammation in eosinophilic bronchitis Source: Eur Respir J 2005; 26: Suppl. 49, 282s Year: 2005 Eosinophilic inflammation and muscle mass in chronic airway disease Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 Eosinophilic lung diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017 Eosinophilic lung diseases Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Eosinophilic lung diseases Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Eosinophilic lung diseases Source: ERS Skills Course 2016 Year: 2016 Gender differences in eosinophilic airway inflammation in allergic and non-allergic asthma Source: Annual Congress 2012 - Mechanisms and modulation of allergic inflammation in the lung Year: 2012